Community-acquired bacteraemic pneumococcal pneumonia in adults: Effect of diminished penicillin susceptibility on clinical outcome

Journal of Infection

Volumn 51, Issue 1, 2005, Pages 69-76

  Bonnard, Philippe ^a   Lescure, F X ^b   Douadi, Y ^b   Schmit, J L ^b   Jounieaux, V ^b   Laurans, G ^b   Eb, F ^b   Ducroix, J P ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Clinical outcome; Community acquired; Diminished penicillin susceptibility; Pneumococcal; Pneumonia

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CEPHALOSPORIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; METRONIDAZOLE; OFLOXACIN; OXACILLIN; PENICILLIN G; PREDNISONE; PRISTINAMYCIN; RIFAMPICIN;

ADULT; AGE; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; CANCER; CANCER CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; FATALITY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; MALE; PENICILLIN RESISTANCE; PROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 21044457676     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2004.08.016     Document Type: Article

References (23)

1. T.J. Marrie Bacteremic pneumococcal pneumonia mortality rate. Is it really different in Sweden? Chest 103 1993 658-660
2. J.G. Bartlett S.F. Dowel1 L.A. Mandell T.M. File D.M. Musher M.J. Fine Practice guidelines for the management of community-acquired pneumonia in adults Clin Inf Dis 37 2000 347-382
3. D. Hansman M.M. Bullen A resistant pneumococcus Lancet 2 1967 264-265
4. I. Niraqi G.P. Kirkpatrick S. Kabins Relapsing pneumococcal meningitidis: Isolation of an organism with decreased susceptibility to penicillin G J Pediatr 85 1974 671-673
5. P. Geslin Résistance du pneumocoque aux antibiotiques en France en 1997 Bull Epidemiol Ann 2 1999 183-186
6. J.M. Gwaltney Jr. M.A. Sande R. Austrian J.O. Hendley Spread of Streptococcus pneumoniae in families II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody J Infect Dis 132 1975 62-68
7. K.M. Kam K.Y. Luey S.M. Fung P.P. Yiu T.J. Harden M.M. Cheung Emergence of multiple-antibiotic-resistant Streptococcus pneumonia in Hong-Kong Antimicrob Agents Chemother 39 1995 2667-2670
8. D.R. Feikin A. Schuchat M. Kolczak N.L. Barrett L.H. Harrisson L. Lefkowitz A. Mc Geer M.M. Farley D.J. Vugia C. Le xau K.R. Stefonek J.E. Patterson J.H. Jorgensen Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997 Am J Public Health 90 2000 223-229
9. G.S. Turett S. Blum B.A. Fazal J.E. Justman E.E. Telzak Penicillin resistance and others predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence Clin Inf Dis 29 1999 321-327
10. J.P. Bedos P. Moine E. Azoulay La résistance doit-elle modifier la prise en charge des pneumopathies et des bactériémies? Med Mal Inf 32 S1 2002 61-70
11. M.J. Fine T.E. Auble D.M. Yealy B.H. Hanusa L.A. Weissfeld D.E. Singer C.M. Coley T.J. Marrie W.N. Kapoor A prediction rule to identify lowrisk patients with community acquired pneumonia N Eng J Med 336 1997 243-250
12. R. Pallarès J. Linares M. Vadillo C. Cabellos F. Manresa P.F. Viladrich R. Martin F. Gudiol Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain N Eng J Med 333 1995 474-480
13. C. Sanchez R. Armengol J. Lite I. Mir J. Garau Penicillin-resistant pneumococci and community acquired pneumonia Lancet 339 1992 988
14. V. Yu C. Chiou C. Feldman A. Ortqvist J. Rello A.D. Morris L.M. Baddour C.M. Luna D.R. Snydman M. Ip W.C. Ko M.B. Chedid A. Andremont K.P. Klugman International Pneumococcal Study Group An international prospective study of pneumococcal bacteremia: Correlation with in vitro resistance, antibiotics administered, and clinical outcome Clin Inf Dis 37 2003 230-237
15. A. Ewig M. Ruiz A. Torres F. Marco J.A. Martinez M. Sanchez J. Mensa Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae Am J Respir Crit Cure Med 159 1999 1835-1842
16. J.F. Moroney A.E. Fiore L.H. Harrison J.E. Patterson M.M. Farley J.H. Jorgensen M. Phelan R.R. Facklam M.S. Cetron R.F. Breiman M. Kolczak Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance Clin Inf Dis 33 2001 797-805
17. J.P. Metlay J. Hofmann M.S. Cetron M.J. Fine M.M. Farley C. Whitney R.F. Breiman Impact of penicillin susceptibility on medical outcomes for adult patients with bacteriemic pneumococcal pneumonia Clin Inf Dis 30 2000 520-528
18. J.J. Ruhe R. Hasbun Streptococcus pneumoniae bacteremia: Duration of previous antibiotic use and association with penicillin resistance Clin Inf Dis 36 2003 1132-1138
19. M.S. Niederman Q.A. Ahmed Community acquired pneumonia in elderly patients Clin Geriatr Med 19 2003 101-120
20. J.C. Butler A. Schuchat Epidemiology of pneumococcal infections in the elderly Drugs Aging 15 Suppl. 1 1999 11-19
21. S. Einarsson M. Kristjansson K.G. Kristinsson G. Kjartansson S. Jonsson Pneumonia caused by penicillin-non-susceptible and penicillin susceptible pneumococci in adults: A case control study Scand J Infect Dis 30 1998 253-256
22. Centers for Disease Control and Prevention Influenza and pneumococcal vaccination levels among adults aged. 65 years-United States Morbid Mortal Wkly Report 47 1998 797-802
23. M. Micoud Vaccination antipneumococcique en France: L'avenir Presse Med 27 Suppl. 1 1998 55-56